Search Results

There are 1068 results for: content related to: Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

  1. You have free access to this content
    Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study

    International Journal of Cancer

    Volume 133, Issue 5, 1 September 2013, Pages: 1204–1213, Giuseppe Stragliotto, Afsar Rahbar, Nina Wolmer Solberg, Anders Lilja, Chato Taher, Abiel Orrego, Birgitta Bjurman, Charlotte Tammik, Petra Skarman, Inti Peredo and Cecilia Söderberg-Nauclér

    Article first published online : 13 MAR 2013, DOI: 10.1002/ijc.28111

  2. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 6, June 2000, Pages: 781–789, Mitsuru Sugawara, Wei Huang, You-Jun Fei, Frederick H. Leibach, Vadivel Ganapathy and Malliga E. Ganapathy

    Article first published online : 20 JUN 2000, DOI: 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7

  3. You have full text access to this OnlineOpen article
    Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation

    American Journal of Transplantation

    Volume 4, Issue 10, October 2004, Pages: 1635–1642, Martin R. Zamora, Mark R. Nicolls, Tony N. Hodges, Jane Marquesen, Todd Astor, Todd Grazia and David Weill

    Article first published online : 20 JUL 2004, DOI: 10.1111/j.1600-6143.2004.00571.x

  4. You have full text access to this OnlineOpen article
    Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 4, Issue 4, April 2004, Pages: 611–620, Carlos Paya, Atul Humar, Ed Dominguez, Kenneth Washburn, Emily Blumberg, Barbara Alexander, Richard Freeman, Nigel Heaton, Mark D. Pescovitz and Valganciclovir Solid Organ Transplant Study Group

    Article first published online : 25 FEB 2004, DOI: 10.1111/j.1600-6143.2004.00382.x

  5. You have full text access to this OnlineOpen article
    Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation

    Transplant International

    Volume 23, Issue 9, September 2010, Pages: 897–906, Francesca Leone, Ahmed Akl, Magali Giral, Jacques Dantal, Gilles Blancho, Jean-Paul Soulillou and Diego Cantarovich

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1432-2277.2010.01073.x

  6. You have full text access to this OnlineOpen article
    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

    Intervention Review

    The Cochrane Library

    Elisabeth M Hodson, Maleeka Ladhani, Angela C Webster, Giovanni FM Strippoli and Jonathan C Craig

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD003774.pub4

  7. You have full text access to this OnlineOpen article
    Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

    Liver Transplantation

    Volume 18, Issue 3, March 2012, Pages: 347–354, Ashley N. Bedel, Trina S. Hemmelgarn and Rohit Kohli

    Article first published online : 24 FEB 2012, DOI: 10.1002/lt.22471

  8. You have full text access to this OnlineOpen article
    Valganciclovir: Recent Progress

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1359–1364, M. D. Pescovitz

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03112.x

  9. You have full text access to this OnlineOpen article
    A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients

    American Journal of Transplantation

    Volume 9, Issue 5, May 2009, Pages: 1134–1141, V. Monforte, C. Lopez, F. Santos, F. Zurbano, M. De La Torre, A. Sole, J. Gavalda, P. Ussetti, R. Lama, J. Cifrian, J. M. Borro, A. Pastor, O. Len, C. Bravo and A. Roman

    Article first published online : 16 MAR 2009, DOI: 10.1111/j.1600-6143.2009.02574.x

  10. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients

    Transplant Infectious Disease

    Volume 12, Issue 3, June 2010, Pages: 195–203, M.D. Pescovitz, R.B. Ettenger, C.F. Strife, J.R. Sherbotie, S.E. Thomas, S. McDiarmid, S. Bartosh, J. Ives, M.R. Bouw and J. Bucuvalas

    Article first published online : 7 DEC 2009, DOI: 10.1111/j.1399-3062.2009.00478.x

  11. You have full text access to this OnlineOpen article
    Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 9, Issue 3, March 2009, Pages: 636–643, W. Vaudry, R. Ettenger, P. Jara, G. Varela-Fascinetto, M. R. Bouw, J. Ives, R. Walker and on behalf of the Valcyte WV16726 study group

    Article first published online : 19 FEB 2009, DOI: 10.1111/j.1600-6143.2008.02528.x

  12. Pharmacokinetics of ganciclovir and valganciclovir in the adult horse

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 36, Issue 5, October 2013, Pages: 441–449, R. J. Carmichael, C. Whitfield and L. K. Maxwell

    Article first published online : 10 JAN 2013, DOI: 10.1111/jvp.12029

  13. Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients

    Clinical Transplantation

    Volume 21, Issue 4, July/August 2007, Pages: 441–448, Federico Oppenheimer, Miguel Gonzalez-Molina and Marta Rubio

    Article first published online : 30 JUN 2007, DOI: 10.1111/j.1399-0012.2007.00612.x

  14. Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study

    Clinical Transplantation

    Volume 24, Issue 6, November/December 2010, Pages: 794–800, Oriol Manuel, Manuel Pascual, Nancy Perrottet, Frédéric Lamoth, Jean-P. Venetz, Laurent A. Decosterd, Thierry Buclin and Pascal R. Meylan

    Article first published online : 24 JAN 2010, DOI: 10.1111/j.1399-0012.2009.01205.x

  15. You have full text access to this OnlineOpen article
    Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients

    American Journal of Transplantation

    Volume 6, Issue 9, September 2006, Pages: 2134–2143, J. A. Khoury, G. A. Storch, D. L. Bohl, R. M. Schuessler, S. M. Torrence, M. Lockwood, M. Gaudreault-Keener, M. J. Koch, B. W. Miller, K. L. Hardinger, M. A. Schnitzler and D. C. Brennan

    Article first published online : 19 JUN 2006, DOI: 10.1111/j.1600-6143.2006.01413.x

  16. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis

    Transplant Infectious Disease

    Volume 14, Issue 3, June 2012, Pages: 248–258, A.P. Wiita, N. Roubinian, Y. Khan, P.V. Chin-Hong, J.P. Singer, J.A. Golden and S. Miller

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1399-3062.2012.00723.x

  17. The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation

    Pediatric Transplantation

    Volume 14, Issue 6, September 2010, Pages: 753–760, E. Lapidus-Krol, R. Shapiro, J. Amir, M. Davidovits, R. Steinberg, E. Mor and Y. Avitzur

    Article first published online : 3 MAY 2010, DOI: 10.1111/j.1399-3046.2010.01330.x

  18. You have full text access to this OnlineOpen article
    CMV: Prevention, Diagnosis and Therapy

    American Journal of Transplantation

    Volume 13, Issue s3, February 2013, Pages: 24–40, C. N. Kotton

    Article first published online : 24 JAN 2013, DOI: 10.1111/ajt.12006

  19. You have full text access to this OnlineOpen article
    Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

    American Journal of Transplantation

    Volume 10, Issue 9, September 2010, Pages: 2026–2032, I. Helanterä, L. Kyllönen, I. Lautenschlager, K. Salmela and P. Koskinen

    Article first published online : 27 AUG 2010, DOI: 10.1111/j.1600-6143.2010.03225.x

  20. You have full text access to this OnlineOpen article
    A Trial of Valganciclovir Prophylaxis for Cytomegalovirus Prevention in Lung Transplant Recipients

    American Journal of Transplantation

    Volume 5, Issue 6, June 2005, Pages: 1462–1468, Atul Humar, Deepali Kumar, Jutta Preiksaitis, Guy Boivin, Deborah Siegal, Jayne Fenton, Kathy Jackson, Sarah Nia and Dale Lien

    Article first published online : 9 APR 2005, DOI: 10.1111/j.1600-6143.2005.00866.x